Literature DB >> 9717720

Characterization of phospholipids in pre-alpha HDL: selective phospholipid efflux with apolipoprotein A-I.

W Zhang1, B Asztalos, P S Roheim, L Wong.   

Abstract

Previously, we have shown that lipid-free apoA-I, when incubated with fibroblasts, will produce lipoproteins of pre-alpha mobility (Asztalos, B. F., et al. 1997. Arterioscler. Thromb. Vasc. Biol. 17: 1630-1636). In order to understand the nature of these pre-alpha particles, we further characterized their lipid content. The pre-alpha particles are high density lipoproteins, having a median density of 1.08 g/ml. They have a surface charge of -18.45 mV. The phospholipid composition of these particles showed that they have 4% each of phosphatidyl ethanolamine and inositol; 69% phosphatidyl choline and 18% sphingomyelin. This phospholipid composition is different from those of plasma HDL (81% phosphatidyl choline, 13% sphingomyelin), plasma membrane on the fibroblasts, and whole fibroblast phospholipid. To demonstrate that the pre-alpha mobility resides in the lipids, lipids from pre-alpha lipoproteins were reconstituted with lipid-free apoA-I. The resultant particles retained their pre-alpha mobility. We conclude that apoA-I may react with specific regions of plasma membrane to acquire this unusual lipid composition and that pre-alpha mobility is caused in part by the unusual phospholipid composition.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9717720

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  9 in total

1.  Raman spectroscopy detects biochemical changes due to proliferation in mammalian cell cultures.

Authors:  Kurt W Short; Susan Carpenter; James P Freyer; Judith R Mourant
Journal:  Biophys J       Date:  2005-03-11       Impact factor: 4.033

2.  Egg consumption modulates HDL lipid composition and increases the cholesterol-accepting capacity of serum in metabolic syndrome.

Authors:  Catherine J Andersen; Christopher N Blesso; Jiyoung Lee; Jacqueline Barona; Dharika Shah; Michael J Thomas; Maria Luz Fernandez
Journal:  Lipids       Date:  2013-03-15       Impact factor: 1.880

Review 3.  HDL lipids and insulin resistance.

Authors:  Andrew N Hoofnagle; Tomas Vaisar; Poulami Mitra; Alan Chait
Journal:  Curr Diab Rep       Date:  2010-02       Impact factor: 4.810

4.  Melittin-Induced Lipid Extraction Modulated by the Methylation Level of Phosphatidylcholine Headgroups.

Authors:  Alexandre Therrien; Michel Lafleur
Journal:  Biophys J       Date:  2016-01-19       Impact factor: 4.033

5.  Triacylglycerol-rich lipoproteins alter the secretion, and the cholesterol-effluxing function, of apolipoprotein E-containing lipoprotein particles from human (THP-1) macrophages.

Authors:  E M Lindholm; A M Palmer; A Graham
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

6.  Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomers.

Authors:  Mary G Sorci-Thomas; John S Owen; Brian Fulp; Shaila Bhat; Xuewei Zhu; John S Parks; Dharika Shah; W Gray Jerome; Mark Gerelus; Manal Zabalawi; Michael J Thomas
Journal:  J Lipid Res       Date:  2012-06-29       Impact factor: 5.922

Review 7.  Structure and function of phosphatidylcholine transfer protein (PC-TP)/StarD2.

Authors:  Keishi Kanno; Michele K Wu; Erez F Scapa; Steven L Roderick; David E Cohen
Journal:  Biochim Biophys Acta       Date:  2007-04-12

8.  Mechanisms responsible for the compositional heterogeneity of nascent high density lipoprotein.

Authors:  Sissel Lund-Katz; Nicholas N Lyssenko; Margaret Nickel; David Nguyen; Palaniappan Sevugan Chetty; Ginny Weibel; Michael C Phillips
Journal:  J Biol Chem       Date:  2013-07-08       Impact factor: 5.157

Review 9.  Sphingomyelin in high-density lipoproteins: structural role and biological function.

Authors:  Roberto Martínez-Beamonte; Jose M Lou-Bonafonte; María V Martínez-Gracia; Jesús Osada
Journal:  Int J Mol Sci       Date:  2013-04-09       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.